Skip to main
MRTX
MRTX logo

Mirati Therapeutics (MRTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Mirati Therapeutics (MRTX) Stock

About Mirati Therapeutics (MRTX)

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.
Market cap$4.12B
Today's volume
Revenue (TTM)
Avg. daily volume1.6M
EBITDA (TTM)
Open
Price / earnings ratio-4.80x
Today's range
Debt / equity
52 week range$27.3 - $64.41
5 year debt / equity2.69x
Beta (LTM)0.48x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 6, 2023
Dividend payable date

Mirati Therapeutics Stock Rating

What analysts recommend for MRTX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 16%
Buy 28%
Hold 56%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 14, 2025, the market cap for MRTX stock is $4.12B

The current P/E ratio for MRTX stock is -4.8

The 52-week high for MRTX stock is $64.41. The current MRTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for MRTX stock is $27.30. The current MRTX stock price $undefined has increased 100.00% from its 52-week low

No, the MRTX stock does not pay dividends to its shareholders

The target price for MRTX stock is $82.08 based on the average of what a group of analyst think MRTX stock could be worth at a future date. This is not a prediction by Public.com

How to buy MRTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MRTX stock

    Navigate to the Explore page. Then, type MRTX into the search bar. When you see MRTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MRTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Mirati Therapeutics Stock Earnings

The value each MRTX share was expected to gain vs. the value that each MRTX share actually gained.

Mirati Therapeutics (MRTX) reported Q3 2023 earnings per share (EPS) of -$2.49, beating estimates of -$2.83 by 12.01%. In the same quarter last year, Mirati Therapeutics's earnings per share (EPS) was -$3.09. Mirati Therapeutics is expected to release next earnings on 11/06/2023, with an earnings per share (EPS) estimate of $0.

Buy Mirati Therapeutics (MRTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.